about
Erythropoietin or darbepoetin for patients with cancerErythropoietin or Darbepoetin for patients with cancerIron deficiency anemia in inflammatory bowel diseaseIron deficiency in gastrointestinal oncologyHematology in palliative medicine.Cognitive Effects of Systemic Therapy in Patients with Breast CancerHigh serum erythropoietin and ferritin levels in conjunction with anemia response in malignant lymphomaDarbepoetin alfa: potential role in managing anemia in cancer patients.Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.Epoetin beta for the treatment of chemotherapy-induced anemia: an update.Factors predicting clinically significant fatigue in women following treatment for primary breast cancer.Iron, anaemia, and inflammatory bowel diseases.Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.Darbepoetin alfa for the treatment of cancer-related anemia: an update.Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life.Safety considerations for erythropoietin treatment in patients with cancer.Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.A case-control study of prevalence of anemia among patients with type 2 diabetesEpoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.Myelophil, a mixture of Astragali Radix and Salviae Radix extract, moderates toxic side effects of fluorouracil in miceAssociation between maternal anaemia and postpartum depression in an urban sample of pregnant women in Iran.Managing anemia in lymphoma and multiple myelomaThe role of the pharmacist in optimizing the use of erythropoietin stimulating agents.Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial.Management of anemia in cancer patients.Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.No association between iron status and self-reported health-related quality of life in 16,375 Danish blood donors: results from the Danish Blood Donor Study.Absolute and Functional Iron Deficiency Anemia among Different Tumors in Cancer Patients in South Part of Iran, 2014Stimulating erythropoiesis in inflammatory bowel disease associated anemia.An exploration of the influences on clinical decision making and the culture of blood transfusion practise in cancer-related anaemia using an ethnographic methodology.The Polish Cancer Anemia Survey (POLCAS): a retrospective multicenter study of 999 cases.Managing anemia in the critically ill patient.A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents.Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based ApproachIntravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: A systematic review and network meta-analysis
P2860
Q24202335-88D9D36C-E341-4F0A-8A2A-308035F0FF20Q24245464-7DFD2D4E-044B-437E-9AB5-2816EAB1BE17Q26795390-B41AF4AA-3D60-440F-ACF5-FEF29D4A2F1EQ27023196-1218A59D-C65D-49F9-9F81-D303954BB304Q33364223-EA062802-037A-4595-9A73-388936FB167AQ34095832-A873676F-413C-4477-B311-5976B9B4DB5AQ35040015-399FAEAE-F5F3-4138-9E3A-76E20661BF5AQ35089120-D654842A-1111-4398-987D-FB3BC4A57E9CQ35104268-C1679CEB-E978-4659-8EC6-4C76570277B8Q35168681-C60291CC-F239-4F0B-82B4-787ACA042959Q35195240-506C8AAD-5643-4155-B6AD-EF2926BCA219Q35596692-CA2F8819-C7FA-4492-B46B-508E0C3A4528Q35648863-493F409C-F08C-4570-89B3-3771872574FDQ35918431-A6E755AB-5215-48E8-9AD5-AB3739E6F4B3Q36147237-5A4D39C9-EF6D-402B-B46B-33092C5390E8Q36689075-11DE1FE3-4126-43C4-AF3C-474F0BE56C4EQ36801561-2481E128-3285-4E7C-AFDD-38FA1C403529Q36866979-FCBC5C9C-B604-47CF-BAAC-B498DBC92E25Q37183442-7F19B8EE-4B68-44FB-8C50-BCB071A4EE05Q37230276-6C9004AD-332A-46C9-B296-568CEEDCDB99Q37248713-67F4481C-9C8A-47E1-A5ED-4F77A56133E9Q37249221-5B3B19E9-016D-4C7C-BAA2-98ACEAA3FDE1Q37252771-99FFB481-A66B-48DC-A90A-FFDCB2ADB232Q37463536-8EDACE3C-E24B-4A85-82FF-D9574DFC7F18Q37564558-474B6250-02D0-4C68-A022-473FC10B7F0EQ37572226-369BC6D8-B9D5-44E9-89CD-E891DAF90518Q37861195-740F4B1E-8355-4DC6-A96C-3894AD3A5DCAQ37982120-EFD5ECF7-34F1-460D-8D60-25FB3BFFEE77Q39020604-E5CF2AAE-2FEB-429C-848B-71976D1C2309Q42285098-8234C656-BA60-4679-8224-919EE38F876DQ42593974-37387051-E4F9-4D89-89C5-AE9DDEA3A5BCQ47412056-6BA24239-3051-4E17-AAB2-61C50BB2A220Q50613206-D3D2E92A-1366-4A22-A278-38A46EA7E53AQ50803255-48E82FEF-4555-4DEB-AD3B-F6D8CB28A7A4Q51985547-8EC80661-EADE-4A67-BED0-C7706ACCB78CQ55366199-66924A06-ACBB-467B-B7E5-8D57B5C6C1A6Q57191817-BD1302F5-60E6-4FFE-B192-DFA85E05827FQ58908160-773124EF-B4D3-47A5-BED0-3CC1FF2F70D2
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Symptomatology of anemia.
@ast
Symptomatology of anemia.
@en
Symptomatology of anemia.
@nl
type
label
Symptomatology of anemia.
@ast
Symptomatology of anemia.
@en
Symptomatology of anemia.
@nl
prefLabel
Symptomatology of anemia.
@ast
Symptomatology of anemia.
@en
Symptomatology of anemia.
@nl
P1433
P1476
Symptomatology of anemia.
@en
P2093
P356
10.1016/S0093-7754(01)90206-4
P433
P577
2001-04-01T00:00:00Z